Literature DB >> 15520196

BRCA1 induces antioxidant gene expression and resistance to oxidative stress.

Insoo Bae1, Saijun Fan, Qinghui Meng, Jeong Keun Rih, Hee Jong Kim, Hyo Jin Kang, Jingwen Xu, Itzhak D Goldberg, Anil K Jaiswal, Eliot M Rosen.   

Abstract

Mutations of the breast cancer susceptibility gene 1 (BRCA1), a tumor suppressor, confer an increased risk for breast, ovarian, and prostate cancers. To investigate the function of the BRCA1 gene, we performed DNA microarray and confirmatory reverse transcription-PCR analyses to identify BRCA1-regulated gene expression changes. We found that BRCA1 up-regulates the expression of multiple genes involved in the cytoprotective antioxidant response, including glutathione S-transferases, oxidoreductases, and other antioxidant genes. Consistent with these findings, BRCA1 overexpression conferred resistance while BRCA1 deficiency conferred sensitivity to several different oxidizing agents (hydrogen peroxide and paraquat). In addition, in the setting of oxidative stress (due to hydrogen peroxide), BRCA1 shifted the cellular redox balance to a higher ratio of reduced to oxidized glutathione. Finally, BRCA1 stimulated antioxidant response element-driven transcriptional activity and enhanced the activity of the antioxidant response transcription factor nuclear factor erythroid-derived 2 like 2 [also called NRF2 (NFE2L2)]. The ability of BRCA1 to stimulate antioxidant response element-dependent transcription and to protect cells against oxidative stress was attenuated by inhibition of nuclear factor erythroid-derived 2 like 2. These findings suggest a novel function for BRCA1, i.e., to protect cells against oxidative stress. This function would be consistent with the postulated role of BRCA1 as a caretaker gene in preserving genomic integrity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15520196     DOI: 10.1158/0008-5472.CAN-04-1119

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  89 in total

1.  Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells.

Authors:  Young Bin Hong; Hyo Jin Kang; Sun Young Kwon; Hee Jeong Kim; Kun Young Kwon; Chi Heum Cho; Jong-Min Lee; Bhaskar V S Kallakury; Insoo Bae
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

2.  Correcting errors in the BRCA1 warning system.

Authors:  Yanping Liang; William J Dearnaley; Nick A Alden; Maria J Solares; Brian L Gilmore; Kevin J Pridham; A Cameron Varano; Zhi Sheng; Elizabeth Alli; Deborah F Kelly
Journal:  DNA Repair (Amst)       Date:  2018-11-22

3.  BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.

Authors:  Ram Fridlich; Devi Annamalai; Rohini Roy; Giana Bernheim; Simon N Powell
Journal:  DNA Repair (Amst)       Date:  2015-03-17

Review 4.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

5.  DIM (3,3'-diindolylmethane) confers protection against ionizing radiation by a unique mechanism.

Authors:  Saijun Fan; Qinghui Meng; Jiaying Xu; Yang Jiao; Lin Zhao; Xiaodong Zhang; Fazlul H Sarkar; Milton L Brown; Anatoly Dritschilo; Eliot M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

6.  Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer.

Authors:  Yanying Huo; Hong Cai; Irina Teplova; Christian Bowman-Colin; Guanghua Chen; Sandy Price; Nicola Barnard; Shridar Ganesan; Vassiliki Karantza; Eileen White; Bing Xia
Journal:  Cancer Discov       Date:  2013-05-06       Impact factor: 39.397

Review 7.  Modulation of oxidative stress as an anticancer strategy.

Authors:  Chiara Gorrini; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

8.  The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

Authors:  Yongxian Ma; Pragati Katiyar; Laundette P Jones; Saijun Fan; Yiyu Zhang; Priscilla A Furth; Eliot M Rosen
Journal:  Mol Endocrinol       Date:  2005-08-18

9.  Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells.

Authors:  Young Bin Hong; Hyo Jin Kang; Hee Jeong Kim; Eliot M Rosen; Sivanesan Dakshanamurthy; Riccardo Rondanin; Riccardo Baruchello; Giuseppina Grisolia; Simoni Daniele; Insoo Bae
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

10.  Increased H2O2 level in exhaled breath condensate in primary breast cancer patients.

Authors:  Robert A Stolarek; Elzbieta Potargowicz; Ewa Seklewska; Jarosław Jakubik; Marek Lewandowski; Arkadiusz Jeziorski; Dariusz Nowak
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-05       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.